Free Trial

Rep. Jefferson Shreve Sells Off Shares of Lam Research Corporation (NASDAQ:LRCX)

Lam Research logo with Computer and Technology background

Representative Jefferson Shreve (R-Indiana) recently sold shares of Lam Research Corporation NASDAQ: LRCX. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in Lam Research stock on May 12th.

Representative Jefferson Shreve also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
  • Sold $100,001 - $250,000 in shares of Walmart NYSE: WMT on 5/12/2025.

Lam Research Stock Down 0.8%

Shares of NASDAQ LRCX traded down $0.82 during mid-day trading on Friday, hitting $96.96. The company had a trading volume of 8,912,992 shares, compared to its average volume of 8,968,377. The company has a market capitalization of $124.02 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 1.38 and a beta of 1.68. The firm has a 50-day simple moving average of $92.49 and a two-hundred day simple moving average of $81.62. The company has a current ratio of 2.45, a quick ratio of 1.64 and a debt-to-equity ratio of 0.39. Lam Research Corporation has a one year low of $56.32 and a one year high of $102.59.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 EPS for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Lam Research had a return on equity of 53.21% and a net margin of 27.18%. The business had revenue of $4.72 billion during the quarter, compared to analysts' expectations of $4.64 billion. During the same quarter last year, the company posted $7.79 earnings per share. Lam Research's quarterly revenue was up 24.4% on a year-over-year basis. On average, equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 9th. Stockholders of record on Wednesday, June 18th were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a dividend yield of 0.95%. The ex-dividend date was Wednesday, June 18th. Lam Research's payout ratio is 25.63%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after purchasing an additional 8,364,375 shares during the last quarter. FMR LLC grew its stake in shares of Lam Research by 1,032.6% in the fourth quarter. FMR LLC now owns 40,031,194 shares of the semiconductor company's stock worth $2,891,453,000 after purchasing an additional 36,496,689 shares during the last quarter. Ameriprise Financial Inc. grew its stake in shares of Lam Research by 950.5% in the fourth quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company's stock worth $2,495,128,000 after purchasing an additional 31,255,726 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Lam Research by 907.1% in the fourth quarter. Geode Capital Management LLC now owns 31,428,010 shares of the semiconductor company's stock worth $2,265,610,000 after purchasing an additional 28,307,499 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Lam Research in the fourth quarter worth $1,661,672,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on LRCX. Deutsche Bank Aktiengesellschaft set a $70.00 price target on Lam Research and gave the stock a "hold" rating in a report on Thursday, April 24th. Evercore ISI boosted their price objective on Lam Research from $95.00 to $99.00 and gave the stock an "outperform" rating in a report on Thursday, April 24th. TD Securities reduced their price objective on Lam Research from $110.00 to $100.00 and set a "buy" rating for the company in a report on Thursday, April 24th. Bank of America reduced their price objective on Lam Research from $110.00 to $90.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. Finally, Oppenheimer restated an "outperform" rating and set a $110.00 price objective (up previously from $80.00) on shares of Lam Research in a report on Tuesday, June 17th. Seven equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $100.57.

Get Our Latest Stock Report on Lam Research

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Lam Research Company Profile

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Articles

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines